Immune “checkpoint” inhibitor treatment found useful against Merkel cell carcinoma in multi-center clinical trial Immunotherapy Before Surgery Could Advance Care of an Aggressive Form of…
Fluorescent radiography images of two wild type (WT, or normal) mice on top and two knockout (KO) mice on bottom. The KO mice are bred…
A team of Johns Hopkins experts has created a clinical guidebook to help hospitals and medical centers rapidly scale up their ability to deliver so-called…
Intense Form of Radiation Slows Disease Progression in Some Men with Prostate Cancer That Has Spread
Highly focused radiation can cause systemic immune response for men with limited spread of prostate cancer Highly focused, intense doses of radiation called stereotactic…
Researchers in the cancer nanomedicine community debate whether use of tiny structures, called nanoparticles, can best deliver drug therapy to tumors passively — allowing…
We understand that you may be experiencing challenges or have questions regarding conducting your research due to COVID-19. If you have a question related to…
All walk-in clinics are now online. East Baltimore Campus Walk-in Clinic Virtual walk-in clinics will be conducted via MS Teams. Please visit the Microsoft Teams…
More than 35 million Americans take statin drugs daily to lower their blood cholesterol levels. Now, in experiments with human cells in the laboratory, researchers…
Johns Hopkins Medicine scientists say they have successfully turned back the biological hands of time, coaxing adult human cells in the laboratory to revert…
A message from Johns Hopkins University Human Resources March 18, 2020 Officials and experts at Johns Hopkins are actively monitoring the outbreak of…
